ArticleCancers2023

Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment.

Ruth Stuckey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.